| Christopher Miller, MD | |
|
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
| (913) 588-5000 | |
| Not Available |
| Full Name | Christopher Miller |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 10 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639598832 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Lawrence Memorial Hospital | Lawrence, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Non-infectious pneumonitis and stomatitis occur more frequently in patients with advanced renal cell carcinoma treated with everolimus than temsirolimus, whereas temsirolimus is associated with a higher incidence of fatigue, rash and asthenia, a retrospective study reports.
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.
EnzymeRx, LLC, a clinical-stage biotechnology company, announced completion of the enrollment of its first clinical trial of pegsitacase (formerly called Uricase-PEG 20), and the recent launch of a second clinical study. Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.
Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).
› Verified 7 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Non-infectious pneumonitis and stomatitis occur more frequently in patients with advanced renal cell carcinoma treated with everolimus than temsirolimus, whereas temsirolimus is associated with a higher incidence of fatigue, rash and asthenia, a retrospective study reports.
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.
EnzymeRx, LLC, a clinical-stage biotechnology company, announced completion of the enrollment of its first clinical trial of pegsitacase (formerly called Uricase-PEG 20), and the recent launch of a second clinical study. Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.
Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Miller, MD 4308 Adams St, Kansas City, KS 66103-3411 Ph: (316) 992-0787 | Christopher Miller, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-5000 |
News Archive
Non-infectious pneumonitis and stomatitis occur more frequently in patients with advanced renal cell carcinoma treated with everolimus than temsirolimus, whereas temsirolimus is associated with a higher incidence of fatigue, rash and asthenia, a retrospective study reports.
Our immune systems are in a constant battle with foreign invaders to keep our bodies healthy. Outside forces like pollution, poor nutrition and new strains of disease keep our immune systems at an overly boosted or inflamed state, which affects energy levels, body and emotional health and overall quality of life. Through inflammatory immune cells, our bodies fight to defend us from this onslaught. Too few of these cells can result in illness, while too many could lead to a high immune response, resulting in heightened inflammation and collateral damage to the body's once-healthy tissues.
EnzymeRx, LLC, a clinical-stage biotechnology company, announced completion of the enrollment of its first clinical trial of pegsitacase (formerly called Uricase-PEG 20), and the recent launch of a second clinical study. Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.
Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).
› Verified 7 days ago
Anne F Stanton, ARNP Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Dept. Of Neurosurgery, Mail Stop 3021, Kansas City, KS 66160 Phone: 913-588-6180 Fax: 913-588-7570 | |
Dr. Joseph Domino, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 | |
Bailey Raine Yekzaman, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 3021, Kansas City, KS 66160 Phone: 913-588-1227 | |
Dr. Jean-luc Kalonda Kabangu, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Dr. Sarah Isobel Woodrow, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6125 Fax: 913-588-7570 | |
Jules M Nazzaro, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-5129 Fax: 913-588-5337 | |
Jeremy Charles Peterson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Hospital School Of, Dept. Of Neurosurgery, 3901 Rainbow Blvd., Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 Fax: 913-588-7570 |